Antimicrobial Agents Practice Questions

Q: What is the drug of choice for urinary tract infections (UTIs) caused by Pseudomonas?

Ciprofloxacin. **Explanation:** **1. Why Ciprofloxacin is the Correct Answer:** *Pseudomonas aeruginosa* is a notorious Gram-negative pathogen known for its intrinsic resistance to many common antibiotics. **Ciprofloxacin**, a second-generation fluoroquinolone, is the drug of choice for oral treatment of pseudomonal UTIs. Its mechanism involves inhibiting **DNA gyrase (Topoisomerase II)** and **Topoisomerase IV**, preventing bacterial DNA replication. It is highly effective because it achieves high concentrations in the urine and possesses excellent bactericidal activity against most strains of *Pseudomonas*. **2. Why the Other Options are Incorrect:** * **Amoxicillin (Option A):** This is a penicillin that is easily degraded by beta-lactamases. *Pseudomonas* is naturally resistant to amoxicillin. * **Amoxiclav (Option B):** While Clavulanic acid protects amoxicillin from some beta-lactamases, it does not extend the spectrum to include *Pseudomonas*. * **Cefixime (Option C):** This is a 3rd-generation oral cephalosporin. While effective against many Enterobacteriaceae (like *E. coli*), it has **no activity** against *Pseudomonas*. **3. NEET-PG High-Yield Clinical Pearls:** * **Anti-Pseudomonal Cephalosporins:** Remember the "3b and 4" rule: **Ceftazidime** (3b) and **Cefepime** (4th gen) are the cephalosporins active against *Pseudomonas*. * **Anti-Pseudomonal Penicillins:** Piperacillin and Ticarcillin. * **Carbapenems:** Imipenem and Meropenem are active, but **Ertapenem** is the "exception" (it has no activity against *Pseudomonas*). * **Aminoglycosides:** Amikacin is generally the most potent aminoglycoside against *Pseudomonas*. * **Safety Note:** Fluoroquinolones like Ciprofloxacin are contraindicated in pregnancy and children due to the risk of **cartilage damage (arthropathy)**.

Q: In the treatment of Pseudomonas infections, carbenicillin is frequently combined with which of the following agents?

Gentamicin. The correct answer is **Gentamicin**. This combination is a classic example of **pharmacodynamic synergy** used in the management of serious *Pseudomonas aeruginosa* infections [1]. **Why Gentamicin is correct:** Carbenicillin (an antipseudomonal penicillin) and Gentamicin (an aminoglycoside) work together through a synergistic mechanism: 1. **Cell Wall Inhibition:** Carbenicillin inhibits bacterial cell wall synthesis, which increases the permeability of the bacterial membrane [3]. 2. **Enhanced Entry:** This structural damage allows Gentamicin to enter the bacterial cell more easily, where it binds to the 30S ribosomal subunit to inhibit protein synthesis [3]. *Note: These drugs should never be mixed in the same IV bottle/syringe as they are chemically incompatible (aminoglycosides are basic and penicillins are acidic), leading to mutual inactivation.* **Why other options are incorrect:** * **A & D (Penicillin/Amoxicillin):** These are narrow or broad-spectrum penicillins that lack significant activity against *Pseudomonas*. Combining two beta-lactams generally does not provide synergy and may increase the risk of toxicity. * **C (Ciprofloxacin):** While Ciprofloxacin has antipseudomonal activity, it is not the standard "textbook" synergistic partner for carbenicillin in the way aminoglycosides are. **NEET-PG High-Yield Pearls:** * **Synergy Rule:** Always remember: **Cell wall synthesis inhibitor + Aminoglycoside = Synergy.** (e.g., Penicillin + Gentamicin for Enterococcal endocarditis) [2]. * **Antipseudomonal Penicillins:** Include Carboxypenicillins (Carbenicillin, Ticarcillin) and Ureidopenicillins (Piperacillin). Piperacillin is currently the most potent. * **Incompatibility:** Aminoglycosides are physically incompatible with beta-lactams *in vitro*. Administer them at different sites or times.

Q: The HIV fusion inhibitor, enfuvirtide, acts at which site?

Gp 41. **Explanation:** **Enfuvirtide** is a unique antiretroviral drug classified as a **Fusion Inhibitor**. To understand its mechanism, one must recall the steps of HIV entry into the CD4+ T cell [3]: 1. **Attachment:** Viral **gp120** binds to the host **CD4 receptor**. 2. **Co-receptor binding:** gp120 undergoes a conformational change to bind to **CCR5 or CXCR4** [2]. 3. **Fusion:** The transmembrane subunit **gp41** undergoes a structural change (forming a six-helix bundle), which pulls the viral and host membranes together, allowing the viral capsid to enter the cell. **Enfuvirtide** mimics a segment of gp41. It binds to the HR1 (heptad repeat 1) region of **gp41**, preventing the necessary conformational change required for membrane fusion [1]. **Analysis of Incorrect Options:** * **Gp 120:** This is the surface subunit responsible for initial attachment. Drugs like **Fostemsavir** (attachment inhibitor) and **Ibalizumab** (post-attachment inhibitor) target this stage, not enfuvirtide. * **P24:** This is a structural protein that forms the viral **capsid**. It is used as a diagnostic marker in early HIV infection (p24 antigen assay) but is not the target of enfuvirtide. * **CXCR4:** This is a host co-receptor [3]. **Maraviroc** is the drug that acts at the entry stage by binding to the **CCR5** co-receptor (it does not target CXCR4) [2]. **High-Yield NEET-PG Pearls:** * **Route of Administration:** Enfuvirtide is the only HIV drug administered **subcutaneously** (it is a synthetic peptide) [1]. * **Side Effects:** Almost 100% of patients develop **injection site reactions** (nodules, erythema). * **Indication:** Used as "salvage therapy" in treatment-experienced patients with multi-drug resistant HIV [1]. * **Mnemonic:** En**fu**virtide prevents **Fu**sion by targeting gp**41** (think: "41 looks like a needle/spike used for fusion").

Q: Cilastatin is combined with which of the following to increase its duration?

Imipenem. **Explanation:** **1. Why Imipenem is the Correct Answer:** Imipenem is a broad-spectrum carbapenem antibiotic. When administered alone, it is rapidly inactivated in the body by the enzyme **Dehydropeptidase-I (DHP-I)**, located in the brush border of the proximal renal tubules. This metabolism results in low urinary concentrations and the formation of potentially nephrotoxic metabolites. **Cilastatin** is a specific, reversible inhibitor of DHP-I. It is combined with Imipenem to: * Prevent its renal degradation, thereby increasing its plasma half-life and duration of action. * Ensure high therapeutic concentrations in the urine. * Reduce the risk of nephrotoxicity. **2. Why Other Options are Incorrect:** * **Carbenicillin & Penicillin G:** These are penicillins. Their duration of action is typically extended by combining them with **Probenecid**, which inhibits their renal tubular secretion, or by using repository forms (e.g., Benzathine Penicillin). They are not metabolized by DHP-I. * **Cefoperazone:** This is a third-generation cephalosporin. It is primarily excreted via bile and does not require a DHP-I inhibitor. It is frequently combined with **Sulbactam** (a beta-lactamase inhibitor) to enhance its spectrum against resistant bacteria. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** "The kill is lastin' with Cilastatin" (It makes Imipenem last longer). * **Newer Carbapenems:** Meropenem, Ertapenem, and Doripenem are **resistant to DHP-I**; therefore, they do *not* require co-administration with Cilastatin. * **Adverse Effect:** Imipenem-Cilastatin carries a higher risk of **seizures**, especially in patients with renal failure or pre-existing CNS lesions. * **Spectrum:** Imipenem is the drug of choice for *Enterobacter* infections and mixed aerobic/anaerobic infections.

Q: What is the latest drug used for the treatment of multidrug-resistant tuberculosis (MDR-TB) patients?

Bedaquiline. **Explanation:** **Bedaquiline** is the correct answer as it represents a paradigm shift in the management of Multidrug-Resistant Tuberculosis (MDR-TB). It is a diarylquinoline that inhibits the enzyme **mycobacterial ATP synthase**, effectively "starving" the bacteria of energy. It was the first new TB drug class approved by the FDA in over 40 years and is now a core component of the WHO-recommended all-oral shorter regimens for MDR-TB. **Analysis of Options:** * **Amithiozone (Thiacetazone):** An older bacteriostatic drug rarely used today due to severe adverse effects, including Stevens-Johnson Syndrome, especially in HIV-positive patients. * **Capreomycin:** A cyclic peptide antibiotic (injectable) formerly used as a second-line agent. Current WHO guidelines prioritize all-oral regimens, moving injectables like Capreomycin to "Group C" (last resort) or phasing them out entirely. * **Linezolid:** While highly effective and used in MDR-TB regimens (Group A), it is an oxazolidinone originally developed for Gram-positive cocci. Bedaquiline is more "novel" in its specific indication and mechanism for TB. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits the proton pump of ATP synthase (encoded by the *atpE* gene). * **Black Box Warning:** Bedaquiline can cause **QT interval prolongation**. It should be monitored closely with ECGs, especially if co-administered with Clofazimine or Delamanid. * **Metabolism:** It is metabolized by **CYP3A4**; hence, its levels are decreased by Rifampicin (a potent inducer). * **BPaL Regimen:** A modern, highly effective 6-month regimen for highly resistant TB consisting of **B**edaquiline, **P**retomanid, and **L**inezolid.

Q: All of the following are direct-acting antiviral agents for Hepatitis C virus (HCV) infections except?

Entecavir. The core concept tested here is the classification of antiviral drugs based on their target virus. **Entecavir** is a potent nucleoside analog (guanosine analog) used primarily for the treatment of **Chronic Hepatitis B Virus (HBV)** infection [2]. It works by inhibiting HBV DNA polymerase [2]. It has no clinical efficacy against the Hepatitis C Virus (HCV) [1]. **Direct-Acting Antivirals (DAAs) for HCV** are classified based on their molecular targets within the HCV replication cycle [1]: * **NS5A Inhibitors (Suffix "-asvir"):** **Ledipasvir** (Option A) belongs to this class. These drugs inhibit the NS5A replication complex. * **NS5B Polymerase Inhibitors (Suffix "-buvir"):** **Beclabuvir** (Option B) is a non-nucleoside NS5B polymerase inhibitor. Other examples include Sofosbuvir. * **NS3/4A Protease Inhibitors (Suffix "-previr"):** **Paritaprevir** (Option D) belongs to this class. These drugs prevent the cleavage of the viral polyprotein. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mnemonic for HCV DAAs:** * **P**revir = **P**rotease (NS3/4A) * **A**svir = NS5**A** * **B**uvir = NS5**B** (Polymerase) 2. **Entecavir** is a first-line agent for HBV due to its high genetic barrier to resistance, unlike Lamivudine [2]. 3. **Ribavirin** is an older, indirect-acting antiviral used for HCV, but it is not classified as a "Direct-Acting Antiviral" (DAA) [3]. 4. **Sofosbuvir** is the "backbone" of most modern HCV regimens and is a nucleotide NS5B inhibitor.

Q: All of the following are effective in giardiasis except?

Co-trimoxazole. **Explanation:** The treatment of **Giardiasis** (caused by the protozoan *Giardia lamblia*) primarily relies on 5-nitroimidazole derivatives and certain nitrofuran compounds. **1. Why Co-trimoxazole is the correct answer:** **Co-trimoxazole** (Sulfamethoxazole + Trimethoprim) is a folate antagonist primarily used for bacterial infections and *Pneumocystis jirovecii*. It has **no clinical efficacy** against *Giardia lamblia* [2]. Therefore, it is the "except" option in this list. **2. Why the other options are incorrect (Effective agents):** * **Metronidazole:** Historically the drug of choice for giardiasis. It acts by forming free radicals that damage the protozoal DNA [3]. * **Tinidazole:** Currently considered the **first-line drug** (often preferred over metronidazole) due to its longer half-life, allowing for a **single-dose** regimen with higher efficacy and better tolerability [3]. * **Furazolidone:** A nitrofuran derivative effective against Giardia. It is particularly useful in **pediatric populations** because it is available in liquid suspension and is generally well-tolerated in children. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** Tinidazole (Single dose of 2g) is preferred over Metronidazole (5-7 day course) [3]. * **In Pregnancy:** **Paromomycin** (a non-absorbable aminoglycoside) is the preferred agent if treatment is essential during the first trimester, as it avoids systemic toxicity. * **Nitazoxanide:** Another highly effective, broad-spectrum antiprotozoal used for Giardia, especially in children [1]. * **Mechanism Note:** Most anti-giardial drugs (Nitroimidazoles) require reductive activation by the enzyme **pyruvate:ferredoxin oxidoreductase (PFOR)** within the parasite [3].

Q: Why is quinine unsafe in pregnancy?

It causes hemolysis. **Explanation:** **1. Why Hemolysis is the Correct Answer:** Quinine is associated with a rare but severe idiosyncratic reaction known as **"Blackwater Fever."** This condition involves massive intravascular hemolysis, hemoglobinemia, and hemoglobinuria (resulting in dark-colored urine). In the context of pregnancy, patients with **G6PD deficiency** are at a significantly higher risk of acute hemolytic anemia when exposed to quinine. Since pregnancy already places a physiological strain on the hematological system, quinine-induced hemolysis can lead to severe maternal anemia and secondary renal failure. **2. Analysis of Incorrect Options:** * **B & C (Hypokalemia/Hyponatremia):** Quinine does not have a primary effect on electrolyte balance. However, it is notorious for causing **hyperinsulinemia**, which leads to **hypoglycemia** (a high-yield side effect in pregnancy). * **D (Smooth Muscle Contraction):** While quinine was historically (and incorrectly) thought to be an abortifacient due to potential uterine contractions, modern evidence shows it does not significantly stimulate the pregnant uterus at therapeutic doses. **3. NEET-PG High-Yield Pearls:** * **Cinchonism:** The classic triad of quinine toxicity includes tinnitus, high-frequency hearing loss, and dizziness. * **Cardiotoxicity:** Quinine is dextrorotatory to quinidine; it can cause QT prolongation (Class IA antiarrhythmic effect). * **Drug of Choice:** Despite these risks, IV Artesunate is now the drug of choice for severe malaria in all trimesters. Quinine is reserved as an alternative or used in combination with Clindamycin for uncomplicated malaria in the first trimester if other options are unavailable. * **Hypoglycemia:** Always monitor blood glucose when administering quinine to a pregnant woman.

Question 1

What is the drug of choice for urinary tract infections (UTIs) caused by Pseudomonas?

Accepted Answer

Ciprofloxacin

Answer

Amoxicillin

Answer

Amoxiclav

Answer

Cefixime

Question 2

In the treatment of Pseudomonas infections, carbenicillin is frequently combined with which of the following agents?

Accepted Answer

Gentamicin

Answer

Penicillin

Answer

Ciprofloxacin

Answer

Amoxicillin

Question 3

The HIV fusion inhibitor, enfuvirtide, acts at which site?

Accepted Answer

Gp 41

Answer

Gp 120

Answer

P24

Answer

CXCR4

Question 4

Cilastatin is combined with which of the following to increase its duration?

Accepted Answer

Imipenem

Answer

Carbenicillin

Answer

Cefoperazone

Answer

Penicillin G

Question 5

What is the latest drug used for the treatment of multidrug-resistant tuberculosis (MDR-TB) patients?

Accepted Answer

Bedaquiline

Answer

Amithiozone

Answer

Capreomycin

Answer

Linezolid

Question 6

All of the following are direct-acting antiviral agents for Hepatitis C virus (HCV) infections except?

Accepted Answer

Entecavir

Answer

Ledipasvir

Answer

Beclabuvir

Answer

Paritaprevir

Question 7

All of the following are effective in giardiasis except?

Accepted Answer

Co-trimoxazole

Answer

Furazolidine

Answer

Metronidazole

Answer

Tinidazole

Question 8

Which of the following statements regarding Colistin is FALSE?

Accepted Answer

All Gram-positive bacteria are susceptible to Colistin.

Answer

It belongs to a group of antimicrobial agents known as polymyxins which were originally isolated from the spore forming soil organism Paenibacillus polymyxa.

Answer

Colistin is a mixture of polymyxin E1 and E2, two bactericidal pentacationic lipopeptides.

Answer

Colistin is generally used to treat infections with multidrug-resistant, extensively drug-resistant, and pandrug-resistant bacteria.

Question 9

What is the drug of choice for the treatment of malaria due to P. vivax in a 25-year-old pregnant female?

Accepted Answer

Chloroquine

Answer

Primaquine

Answer

Sulfadoxine-pyrimethamine

Answer

Quinine

Question 10

Why is quinine unsafe in pregnancy?

Accepted Answer

It causes hemolysis

Answer

It causes hypokalemia

Answer

It causes hyponatremia

Answer

It causes smooth muscle contraction

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?